Mammoth Biosciences logo

Mammoth Biosciences

Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.

5

Funding Rounds

$263.1m

Money raised

Overview

Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.

Funding series

Funding Series Analysis

The company Mammoth Biosciences has raised a total of $45m in funding over 5 rounds.

Key Insights:

  • Mammoth Biosciences Series B round, January 2020: $45m
  • Mammoth Biosciences funding round, August 2018: $23m
  • Mammoth Biosciences Series D round, September 9, 2021: $195m
  • Mammoth Biosciences Seed round, May 2017: $120k
Mammoth Biosciences logo
Mammoth Biosciences Series B round, January 2020 $45m
Mammoth Biosciences logo
Mammoth Biosciences Seed round, May 2017 $120k
Mammoth Biosciences logo
Mammoth Biosciences funding round, August 2018 $23m
Mammoth Biosciences logo
Mammoth Biosciences Series D round, September 9, 2021 $195m

Industries

Mammoth Biosciences is active in the following industries:
  • In-vitro diagnostics (IVD)
  • Diagnostic tools
  • Bioinformatics
  • Biomedical engineering
  • Technology
  • Synthetic biology
  • Biotechnology
  • Biology
  • Genomics
  • Genome editing
  • Regenerative medicine
  • Healthcare
  • Tissue engineering
  • Engineering